z-logo
open-access-imgOpen Access
Improving colon cancer therapy with a new promising small-molecule activator of the p53-pathway through disruption of p53-MDM2/MDMX interactions
Author(s) -
Liliana Raimundo,
Lucı́lia Saraiva,
Margarida Espadinha,
Joana Soares,
Joana B. Loureiro,
Juliana Calheiros,
Naïr Nazareth,
Joana Almeida,
Marco G. Alves,
Maria M. M. Santos
Publication year - 2019
Publication title -
proceedings of 7th international electronic conference on medicinal chemistry
Language(s) - English
Resource type - Conference proceedings
DOI - 10.3390/ecmc2019-06306
Subject(s) - mdmx , mdm2 , activator (genetics) , cancer research , cancer therapy , colorectal cancer , cancer , chemistry , medicine , apoptosis , biochemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom